Global Hepatitis Therapeutics Market Size & Outlook
Global hepatitis therapeutics market, 2021-2033 (US$M)
Global hepatitis therapeutics market highlights
- The global hepatitis therapeutics market generated a revenue of USD 16,795.3 million in 2024 and is expected to reach USD 23,621.8 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 3.9% by 2033.
- In terms of segment, hepatitis a accounted for a revenue of USD 17,356.5 million in 2024.
- Hepatitis A is the most lucrative disease segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
Global data book summary
| Market revenue in 2024 | USD 16,795.3 million |
| Market revenue in 2033 | USD 23,621.8 million |
| Growth rate | 3.9% (CAGR from 2025 to 2033) |
| Largest segment | Hepatitis a |
| Fastest growing segment | Hepatitis A |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hepatitis A |
Other key industry trends
- In terms of revenue, the North America accounted for 40.7% of the global hepatitis therapeutics market in 2024.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hepatitis Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GSK plc | View profile | - | - | - |
| Bristol-Myers Squibb Company | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Cipla | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.cipla.com |
| Zydus Lifesciences | View profile | 10001+ | Ahmedabad, Gujarat, India, Asia | https://zyduslife.com/ |
| Gilead Sciences Inc | View profile | 18000 | 333 Lakeside Drive, Foster, CA, United States, 94404 | https://www.gilead.com |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Global hepatitis therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hepatitis therapeutics market will help companies and investors design strategic landscapes.
Hepatitis a was the largest segment with a revenue share of 103.34% in 2024. Horizon Databook has segmented the Global hepatitis therapeutics market based on hepatitis a covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Hepatitis Therapeutics Disease Outlook (Revenue, USD Million, 2021-2033)
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Others
- Global Hepatitis Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Hospital Pharmacies
- Drug Stores and Retail Pharmacies
- Others
Reasons to subscribe to Global hepatitis therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global hepatitis therapeutics market databook
-
Our clientele includes a mix of hepatitis therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global hepatitis therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global hepatitis therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global hepatitis therapeutics market size, by regions, 2021-2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
